HALO logo

Halozyme Therapeutics, Inc. (HALO) Cash From Investing

Annual CFI:

-$262.72M-$165.81M(-171.10%)
December 31, 2024

Summary

  • As of today, HALO annual cash from investing is -$262.72 million, with the most recent change of -$165.81 million (-171.10%) on December 31, 2024.
  • During the last 3 years, HALO annual cash from investing has risen by +$143.57 million (+35.34%).
  • HALO annual cash from investing is now -435.30% below its all-time high of $78.35 million, reached on December 31, 2020.

Performance

HALO Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHALOcash flow metrics

Quarterly CFI:

$84.79M+$175.21M(+193.77%)
June 30, 2025

Summary

  • As of today, HALO quarterly cash from investing is $84.79 million, with the most recent change of +$175.21 million (+193.77%) on June 30, 2025.
  • Over the past year, HALO quarterly cash from investing has increased by +$126.83 million (+301.69%).
  • HALO quarterly cash from investing is now at all-time high.

Performance

HALO Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHALOcash flow metrics

TTM CFI:

-$143.64M+$126.83M(+46.89%)
June 30, 2025

Summary

  • As of today, HALO TTM cash from investing is -$143.64 million, with the most recent change of +$126.83 million (+46.89%) on June 30, 2025.
  • Over the past year, HALO TTM cash from investing has increased by +$72.82 million (+33.64%).
  • HALO TTM cash from investing is now -212.15% below its all-time high of $128.08 million, reached on September 30, 2019.

Performance

HALO TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherHALOcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

HALO Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-171.1%+301.7%+33.6%
3Y3 Years+35.3%+119.5%+82.1%
5Y5 Years-4634.6%+612.6%-39.6%

HALO Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-171.1%+46.0%at high+150.6%-1713.1%+81.7%
5Y5-Year-435.3%+46.0%at high+119.5%-283.3%+82.1%
All-TimeAll-Time-435.3%+46.0%at high+119.5%-212.2%+82.1%

HALO Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
$84.79M(+193.8%)
-$143.64M(+46.9%)
Mar 2025
-
-$90.42M(-406.7%)
-$270.46M(-2.9%)
Dec 2024
-$262.72M(-171.1%)
$29.48M(+117.6%)
-$262.72M(+12.6%)
Sep 2024
-
-$167.48M(-298.4%)
-$300.49M(-38.8%)
Jun 2024
-
-$42.04M(+49.2%)
-$216.46M(-81.2%)
Mar 2024
-
-$82.68M(-897.2%)
-$119.43M(-23.2%)
Dec 2023
-$96.91M(+80.1%)
-$8.29M(+90.1%)
-$96.91M(-7.2%)
Sep 2023
-
-$83.45M(-251.7%)
-$90.36M(-1040.7%)
Jun 2023
-
$54.99M(+191.4%)
-$7.92M(+98.4%)
Mar 2023
-
-$60.16M(-3345.7%)
-$497.86M(-2.2%)
Dec 2022
-$487.00M(-19.9%)
-$1.75M(-73.2%)
-$487.00M(+37.9%)
Sep 2022
-
-$1.01M(+99.8%)
-$784.73M(+2.0%)
Jun 2022
-
-$434.95M(-782.2%)
-$800.67M(-95.1%)
Mar 2022
-
-$49.30M(+83.5%)
-$410.34M(-1.0%)
Dec 2021
-$406.29M(-618.5%)
-$299.47M(-1666.4%)
-$406.29M(-739.8%)
Sep 2021
-
-$16.95M(+62.0%)
-$48.38M(+21.4%)
Jun 2021
-
-$44.62M(+1.4%)
-$61.52M(-1129.2%)
Mar 2021
-
-$45.25M(-177.4%)
-$5.00M(-106.4%)
Dec 2020
$78.35M(+1512.0%)
$58.44M(+294.2%)
$78.35M(+176.1%)
Sep 2020
-
-$30.09M(-352.9%)
-$102.91M(-223.5%)
Jun 2020
-
$11.90M(-68.8%)
-$31.81M(-949.0%)
Mar 2020
-
$38.11M(+131.0%)
$3.75M(+167.5%)
Dec 2019
-$5.55M(-322.6%)
-$122.82M(-399.6%)
-$5.55M(-104.3%)
Sep 2019
-
$41.00M(-13.6%)
$128.08M(+4.8%)
Jun 2019
-
$47.46M(+64.7%)
$122.27M(+81.9%)
Mar 2019
-
$28.81M(+166.6%)
$67.21M(+2595.8%)
Dec 2018
$2.49M(+101.5%)
$10.81M(-69.3%)
$2.49M(+101.6%)
Sep 2018
-
$35.19M(+562.6%)
-$157.30M(+3.0%)
Jun 2018
-
-$7.61M(+78.8%)
-$162.21M(+20.4%)
Mar 2018
-
-$35.90M(+75.9%)
-$203.90M(-24.5%)
Dec 2017
-$163.73M(-113.3%)
-$148.99M(-592.0%)
-$163.73M(-2698.5%)
Sep 2017
-
$30.28M(+161.4%)
$6.30M(+140.0%)
Jun 2017
-
-$49.29M(-1255.7%)
-$15.74M(-147.5%)
Mar 2017
-
$4.26M(-79.7%)
$33.12M(+143.1%)
Dec 2016
-$76.77M(-1403.8%)
$21.05M(+155.2%)
-$76.77M(+31.8%)
Sep 2016
-
$8.25M(+1995.6%)
-$112.57M(-12.0%)
Jun 2016
-
-$435.00K(+99.6%)
-$100.52M(-12.5%)
Mar 2016
-
-$105.62M(-615.8%)
-$89.31M(-1616.9%)
Dec 2015
$5.89M(+117.9%)
-$14.76M(-172.7%)
$5.89M(-82.7%)
Sep 2015
-
$20.29M(+88.4%)
$34.13M(+107.3%)
Jun 2015
-
$10.77M(+203.4%)
$16.46M(+9245.0%)
Mar 2015
-
-$10.42M(-177.3%)
-$180.00K(+99.5%)
Dec 2014
-$32.95M(+31.2%)
$13.48M(+413.0%)
-$32.95M(+25.8%)
Sep 2014
-
$2.63M(+144.8%)
-$44.42M(+6.2%)
Jun 2014
-
-$5.87M(+86.4%)
-$47.37M(-13.9%)
Mar 2014
-
-$43.19M(-2241.3%)
-$41.58M(+13.1%)
Dec 2013
-$47.87M
$2.02M(+720.6%)
-$47.87M(+5.1%)
DateAnnualQuarterlyTTM
Sep 2013
-
-$325.00K(-306.3%)
-$50.43M(-0.3%)
Jun 2013
-
-$80.00K(+99.8%)
-$50.27M(+1.3%)
Mar 2013
-
-$49.48M(-9066.5%)
-$50.91M(-3503.0%)
Dec 2012
-$1.41M(-70.5%)
-$539.80K(-222.3%)
-$1.41M(+1.2%)
Sep 2012
-
-$167.50K(+76.8%)
-$1.43M(-9.9%)
Jun 2012
-
-$721.50K(-4666.5%)
-$1.30M(-113.5%)
Mar 2012
-
$15.80K(+102.8%)
-$609.70K(+26.4%)
Dec 2011
-$828.50K(-28.2%)
-$557.00K(-1328.2%)
-$828.50K(-37.6%)
Sep 2011
-
-$39.00K(-32.2%)
-$602.20K(+3.5%)
Jun 2011
-
-$29.50K(+85.5%)
-$623.80K(+10.9%)
Mar 2011
-
-$203.00K(+38.6%)
-$700.40K(-8.4%)
Dec 2010
-$646.50K(+55.7%)
-$330.70K(-445.7%)
-$646.40K(+26.5%)
Sep 2010
-
-$60.60K(+42.9%)
-$879.10K(+9.3%)
Jun 2010
-
-$106.10K(+28.8%)
-$969.40K(+24.9%)
Mar 2010
-
-$149.00K(+73.6%)
-$1.29M(+11.6%)
Dec 2009
-$1.46M(-26.0%)
-$563.40K(-273.4%)
-$1.46M(-27.0%)
Sep 2009
-
-$150.90K(+64.7%)
-$1.15M(+19.8%)
Jun 2009
-
-$427.80K(-34.1%)
-$1.43M(-12.6%)
Mar 2009
-
-$319.00K(-26.4%)
-$1.27M(-9.8%)
Dec 2008
-$1.16M(+51.0%)
-$252.40K(+42.0%)
-$1.16M(+40.2%)
Sep 2008
-
-$435.40K(-63.1%)
-$1.94M(+0.1%)
Jun 2008
-
-$267.00K(-30.2%)
-$1.94M(+19.4%)
Mar 2008
-
-$205.00K(+80.2%)
-$2.41M(-1.9%)
Dec 2007
-$2.37M(-548.4%)
-$1.03M(-136.6%)
-$2.37M(-64.1%)
Sep 2007
-
-$436.70K(+40.5%)
-$1.44M(-24.2%)
Jun 2007
-
-$734.50K(-356.5%)
-$1.16M(-138.5%)
Mar 2007
-
-$160.90K(-47.2%)
-$486.80K(-33.4%)
Dec 2006
-$364.80K(-4.0%)
-$109.30K(+30.0%)
-$364.80K(-38.8%)
Sep 2006
-
-$156.20K(-158.6%)
-$262.90K(-29.3%)
Jun 2006
-
-$60.40K(-55.3%)
-$203.40K(+21.5%)
Mar 2006
-
-$38.90K(-425.7%)
-$259.10K(+26.2%)
Dec 2005
-$350.90K(-53.9%)
-$7400.00(+92.3%)
-$350.90K(+23.6%)
Sep 2005
-
-$96.70K(+16.7%)
-$459.00K(-18.9%)
Jun 2005
-
-$116.10K(+11.2%)
-$386.20K(-22.0%)
Mar 2005
-
-$130.70K(-13.2%)
-$316.60K(-38.9%)
Dec 2004
-$228.00K(>-9900.0%)
-$115.50K(-383.3%)
-$227.90K(-328.4%)
Sep 2004
-
-$23.90K(+48.6%)
-$53.20K(-21.2%)
Jun 2004
-
-$46.50K(-10.7%)
-$43.90K(-4.5%)
Mar 2004
-
-$42.00K(-170.9%)
-$42.00K(>-9900.0%)
Dec 2003
$0.00(0.0%)
$59.20K(+505.5%)
$0.00(+100.0%)
Sep 2003
-
-$14.60K(+67.3%)
-$34.20K(-74.5%)
Jun 2003
-
-$44.60K(>-9900.0%)
-$19.60K(>-9900.0%)
Mar 2003
-
$0.00(-100.0%)
$0.00(0.0%)
Dec 2002
$0.00(0.0%)
$25.00K(>+9900.0%)
$0.00(+100.0%)
Sep 2002
-
$0.00(+100.0%)
-$25.00K(0.0%)
Jun 2002
-
-$25.00K(>-9900.0%)
-$25.00K(>-9900.0%)
Mar 2002
-
$0.00
$0.00
Dec 2001
$0.00
-
-

FAQ

  • What is Halozyme Therapeutics, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Halozyme Therapeutics, Inc.?
  • What is Halozyme Therapeutics, Inc. annual cash from investing year-on-year change?
  • What is Halozyme Therapeutics, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Halozyme Therapeutics, Inc.?
  • What is Halozyme Therapeutics, Inc. quarterly cash from investing year-on-year change?
  • What is Halozyme Therapeutics, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Halozyme Therapeutics, Inc.?
  • What is Halozyme Therapeutics, Inc. TTM cash from investing year-on-year change?

What is Halozyme Therapeutics, Inc. annual cash from investing?

The current annual cash from investing of HALO is -$262.72M

What is the all-time high annual cash from investing for Halozyme Therapeutics, Inc.?

Halozyme Therapeutics, Inc. all-time high annual cash from investing is $78.35M

What is Halozyme Therapeutics, Inc. annual cash from investing year-on-year change?

Over the past year, HALO annual cash from investing has changed by -$165.81M (-171.10%)

What is Halozyme Therapeutics, Inc. quarterly cash from investing?

The current quarterly cash from investing of HALO is $84.79M

What is the all-time high quarterly cash from investing for Halozyme Therapeutics, Inc.?

Halozyme Therapeutics, Inc. all-time high quarterly cash from investing is $84.79M

What is Halozyme Therapeutics, Inc. quarterly cash from investing year-on-year change?

Over the past year, HALO quarterly cash from investing has changed by +$126.83M (+301.69%)

What is Halozyme Therapeutics, Inc. TTM cash from investing?

The current TTM cash from investing of HALO is -$143.64M

What is the all-time high TTM cash from investing for Halozyme Therapeutics, Inc.?

Halozyme Therapeutics, Inc. all-time high TTM cash from investing is $128.08M

What is Halozyme Therapeutics, Inc. TTM cash from investing year-on-year change?

Over the past year, HALO TTM cash from investing has changed by +$72.82M (+33.64%)
On this page